Danish Drug Co. to Build Iran Plant
Economy, Business And Markets

Danish Drug Co. to Build Iran Plant

Pharmaceutical giant Novo Nordisk said on Tuesday it would invest millions in Iran, joining a still very small group of European companies to have announced concrete deals in Tehran after it struck a deal on its nuclear program.
Novo Nordisk, the world’s largest diabetes drugs maker, said it would build a €70 million ($78 million) manufacturing plant in Iran. It already has a subsidiary in the country selling insulin and employing 130 people there since 2005, Reuters reported.


Short URL : https://goo.gl/0R7gPQ
  1. https://goo.gl/qmV7oa
  • https://goo.gl/Za08Q4
  • https://goo.gl/v5vePr
  • https://goo.gl/Lfmn0E
  • https://goo.gl/WvLriF

You can also read ...

How China Became Iran’s Coziest Trade Partner?
From bilateral trade to finance contracts and civil projects,...
Iranian Banking Sector Awaits Full JCPOA Benefits
Iran’s Deputy Foreign Minister Abbas Araqchi addressed various...
The economy of the Islamic Republic of Iran has been tied to political and foreign affairs developments over the years.
This is the Financial Tribune’s last edition of the current...
All-Out Growth in Interbank Market
The Central Bank of Iran has released its latest data on the...
President Hassan Rouhani on Sunday spoke to reporters after the last Cabinet meeting of the current year.
President Hassan Rouhani on Sunday outlined his administration...
Iran has more than 37 billion tons of proven mineral reserves and 57 billion tons of potential reserves.
Iran exported more than 58.09 million tons of mineral products...